News
Shukra Pharmaceuticals standalone net profit rises 340.74% in the September 2025 quarter
14-Nov-2025 | 15:48
Sales rise 5.76% to Rs 5.88 crore
Net profit of Shukra Pharmaceuticals rose 340.74% to Rs 2.38 crore in the quarter ended September 2025 as against Rs 0.54 crore during the previous quarter ended September 2024. Sales rose 5.76% to Rs 5.88 crore in the quarter ended September 2025 as against Rs 5.56 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 5.88 | 5.56 | 6 |
| OPM % | -6.97 | 12.05 | - |
| PBDT | 1.01 | 1.58 | -36 |
| PBT | 0.20 | 0.88 | -77 |
| NP | 2.38 | 0.54 | 341 |
Powered by Capital Market - Live News